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Abstract: Enzyme orthologs sharing identical primary functions can have different promiscuous 
activities. While it is possible to mine this natural diversity to obtain useful biocatalysts, generating 
comparably rich ortholog diversity is difficult, as it is the product of deep evolutionary processes 
occurring in a multitude of separate species and populations. Here, we take a first step in recapitulating 
the depth and scale of natural ortholog evolution on laboratory timescales. Using a continuous directed 
evolution platform called OrthoRep, we rapidly evolved the Thermotoga maritima tryptophan synthase 
β-subunit (TmTrpB) through multi-mutation pathways in many independent replicates, selecting only on 
TmTrpB’s primary activity (synthesizing L-tryptophan from indole and L-serine). We find that the 
resulting sequence-diverse TmTrpB variants span a range of substrate profiles useful in industrial 
biocatalysis and suggest that the depth and scale of evolution that OrthoRep affords will be generally 
valuable in enzyme engineering and the evolution of new biomolecular functions. 
 
Introduction 
 
Natural enzymes typically have many orthologs. While the 
primary activity of orthologous enzymes is largely the same,1 
promiscuous functions not under selective pressure can 
vary widely.2,3 Such variation may be attributed to the deep 
and distinct evolutionary histories shaping each ortholog, 
including long periods of neutral drift, recalibration of primary 
activity, and adaptation to new host environments such as 
temperature. These rich histories act to produce extensive 
genetic diversity, which underpins different promiscuity 
profiles.2 
 
Diversity in promiscuous functions across orthologs is of 
both fundamental and practical importance. An enzyme’s 
reserve of promiscuous activities dictates what secondary 
reactions, environmental changes, or niches the enzyme 
can accommodate.4,5 Diversity in promiscuous activities 
therefore contributes to the basic robustness of life and 
adaptation. An enzyme’s reserve of promiscuous activities 
can also be mined in the application of enzymes for 
biocatalysis.6,7 Ortholog diversity therefore expands the 
range of reactions at the disposal of enzyme engineers, 
supporting the growing role of “green” enzymatic processes 
in the chemical and pharmaceutical industries.8–10 
Inspired by the remarkable ability of enzyme orthologs to 
encompass promiscuous activities, we asked whether we 
could extend the substrate scope of useful enzymes by 
evolving multiple versions of an enzyme in the laboratory, 
selecting only for its primary function. Although this idea has 
been explored before using classical directed evolution 
approaches, most notably through the generation of cryptic 
genetic variation with neutral drift libraries,11–14 we 
recognized that our recently developed continuous evolution 
system, OrthoRep, may be considerably better poised for 
this challenge.15,16 Classical directed evolution mimics 
evolution through an iterative procedure that involves 
diversifying a gene of interest (GOI) in vitro (e.g., through 
error-prone PCR), transforming the resulting GOI library into 
cells, and selecting or screening for desired activities, where 
each cycle of this procedure represents one step in an 
evolutionary search.17 However, since each cycle is 
manually staged, classical directed evolution does not 
readily admit depth and scale during exploration of 
functional sequence space — it is difficult to carry out many 
iterations to mimic lengthy evolutionary searches (depth), let 
alone do so in many independent experiments (scale). Yet 
evolutionary depth and scale are precisely the two 
characteristics responsible for ortholog diversity in nature. 
Natural orthologs have diversified from their ancestral 
parent over great evolutionary timescales, allowing for the 
traversal of long mutational pathways shaped by complex 
selection histories (depth). Natural orthologs are also the 
result of numerous independent evolutionary lineages, since 
spatially separated species and populations are free to take 
divergent mutational paths and experience different 
environments (scale). Systems that better mimic the depth 
and scale of natural enzyme evolution, but on laboratory 
timescales, are thus needed for the effective generation of 
enzyme variants that begin to approach the genetic and 
promiscuity profile diversity of orthologs. 
OrthoRep is such a system. In OrthoRep, an orthogonal 
error-prone DNA polymerase durably hypermutates an 
orthogonal plasmid (p1) without raising the mutation rate of 
the host Saccharomyces cerevisiae genome.16 Thus, GOIs 
encoded on p1 rapidly evolve when cells are simply 
passaged under selection. By reducing the manual stages 
of classical directed evolution down to a continuous process 
where cycles of diversification and selection occur 
autonomously in vivo, OrthoRep readily accesses depth and 
scale in evolutionary search.16,18 Here, we apply OrthoRep 
to the evolution of the Thermotoga maritima tryptophan 
synthase β-subunit (TmTrpB) in multiple independent 
continuous evolution experiments, each carried out for at 
least 100 generations. While we only pressured TmTrpB to 
improve its primary activity of coupling indole and serine to 
produce tryptophan, the large number of independent 
evolution experiments we ran (scale) and the high degree of 
adaptation in each experiment (depth) resulted in a panel of 
variants encompassing expanded promiscuous activity with 
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indole analogs. In addition to the immediate value of these 
newly evolved TmTrpBs in the synthesis of tryptophan 
analogs, our study offers a new template for enzyme 
engineering where evolutionary depth and scale is 
leveraged on laboratory timescales to generate effective 
variant collections covering broad substrate scope. 
 
Results 
 
Establishing a selection system for the evolution of 
TmTrpB variants 
 
To evolve TmTrpB variants using OrthoRep, we first needed 
to develop a selection where yeast would rely on TmTrpB’s 
primary enzymatic activity for growth. TmTrpB catalyzes the 
PLP-dependent coupling of L-serine and indole to generate 
L-tryptophan (Trp) in the presence of the tryptophan 
synthase α-subunit, TmTrpA.19 In T. maritima and all other 
organisms that contain a heterodimeric tryptophan synthase 
complex, TrpA produces the indole substrate that TrpB uses 
and the absence of TrpA significantly attenuates the activity 
of TrpB through loss of allosteric activation.19,20 TRP5 is the 
S. cerevisiae homolog of this heterodimeric enzyme 
complex, carrying out both TrpA and TrpB reactions and 
producing Trp for the cell. We reasoned that by deleting the 
TRP5 gene and forcing S. cerevisiae to rely on TmTrpB 
instead, cells would be pressured to evolve high stand-alone 
TmTrpB activity in order to produce the essential amino acid 
Trp in indole-supplemented media (Fig. 1a). This selection 
pressure would also include thermoadaptation, as yeast 
grow at mesophilic temperatures in contrast to the 
thermophilic source of TmTrpB. Therefore, the selection on 
TmTrpB’s primary activity would be multidimensional — 
stand-alone function, temperature, and neutral drift 
implemented when desired — and could result in complex 
evolutionary pathways that serve our goal of maximizing 
functional variant diversity across replicate evolution 
experiments. In addition, the multidimensional selection also 
serves practical goals as stand-alone activity is useful in 
biosynthetic applications (enzyme complexes are difficult to 
express and use in vitro) and activity at mesophilic 
temperatures is more compatible with heat-labile substrates, 
industrial processes where heating costs can compound, or 
in vivo applications in model mesophilic hosts (e.g. S. 
cerevisiae or Escherichia coli). 
 
To test this selection, we turned to a positive control TmTrpB 
variant called TmTriple. This variant was previously 
engineered to enable stand-alone activity, free from 
dependence on allosteric activation by TrpA, through a 
minimal set of three mutations.7  We found that TmTriple 
rescued TRP5 function in a Dtrp5 strain in an indole-
dependent manner, validating our selection (Supplementary 
Fig. 1). Notably, TmTriple, along with other TrpB variants 
tested, only supported complementation when expressed 
from a high-strength promoter (Supplementary Figs. 1a and 
1b). This highlighted the opportunity for substantial 
adaptation and drift even in evolution experiments that start 
from already engineered TmTrpB variants. 
 
Continuous evolution of TmTrpB with depth and scale 
 
We encoded wild-type (wt) TmTrpB, TmTriple, as well as a 
nonsense mutant of TmTriple, TmTripleQ90*, onto 
OrthoRep’s p1 plasmid, which is replicated by a highly error-
prone orthogonal DNA polymerase. TmTripleQ90* was 
included because reversion of the stop codon at position 90 
in TmTripleQ90* would act as an early indication that 
adaptation was occurring, giving us confidence to continue 
passaging our evolution experiments for several weeks to 
maximize evolutionary search depth. In all three OrthoRep 
Dtrp5 strains, the initial TmTrpB sequences enabled only 
minimal indole-dependent complementation 
(Supplementary Fig. 1c). This was expected for wt TmTrpB, 
which has low stand-alone enzymatic activity and 
TmTripleQ90*, which has a premature stop codon; and was 
unsurprising for TmTriple, since TmTriple displayed indole-
dependent complementation only when artificially 
overexpressed (Supplementary Fig. 1a). 
 
To continuously evolve TmTrpB, we passaged cells 
encoding wt TmTrpB, TmTriple, or TmTripleQ90* on 
OrthoRep in the presence of 100 μM indole while reducing 
the amount of Trp in the medium over time. In total, six 100 
mL and twenty 3 mL cultures were passaged, each 
representing a single independent evolutionary trajectory. 
Passages were carried out as 1:100 dilutions where Trp 
concentrations were decreased in the (N+1)th passage if 
cells grew quickly in the Nth passage, until Trp was fully 
omitted. All six of the 100 mL cultures, and four of the twenty 
3 mL cultures fully adapted and were capable of robust 
growth in indole-supplemented media lacking Trp after 90–
130 generations (13–20 passages) (Fig. 1b, Supplementary 
Table 1). Populations that did not achieve growth in the 
absence of Trp still adapted, but stopped improving at ~5 
µM supplemented Trp, suggesting a suboptimal local fitness 
maximum, though it is unknown if they would have adapted 
further had the experiment continued. Cultures that did 
adapt fully were passaged for an additional ~40 generations 
without increasing selection stringency to allow for 
accumulation of further diversity through neutral drift. 
 
For each of the 10 fully adapted populations, we PCR-
amplified and bulk-sequenced the TmTrpB alleles on the p1 
plasmid. Mutations relative to the parent TmTrpB variant 
detected at >50% frequency in each population were 
deemed consensus mutations for that population, with the 
exception of reversion of the stop codon in populations 
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evolving TmTripleQ90*. This stop codon reversion occurred 
at 100% frequency in the relevant populations and was not 
counted in any subsequent analyses due to its triviality. An 
average of 5.6 (± 2.3 s.d.) and a range of 3–11 consensus 
amino acid changes per population were observed (Fig. 1c, 
Supplementary Table 2). Some of these mutations occurred 
at residues previously identified as relevant in 
conformational dynamics (e.g., N167D and S302P).20–22 
Most mutations observed, however, have not been 
previously identified in laboratory engineering experiments, 
suggesting that even the consensus of these populations 
explored new regions of TmTrpB’s fitness landscape, doing 
so with diversity across replicates (Fig. 1c) that might 
translate to diversity in promiscuous activities across 
evolved variants. 
 
Evolved TmTrpB variants improve Trp production in 
vivo and contain cryptic genetic variation 
 
To ensure that evolved TmTrpB variants, and not potential 
host genomic mutations, were primarily responsible for each 
population’s adaptation, we cloned individual TmTrpBs into 
a standard low copy yeast nuclear plasmid under a promoter 
that approximates expression from p1,23,24 transformed the 
variants into a fresh Dtrp5 strain, and tested for their ability 
to support indole-dependent growth in the absence of Trp  
Fig. 1 | OrthoRep-mediated continuous in vivo evolution of TmTrpB to generate many diverse, functional variants. a, Pipeline 
for the use of OrthoRep continuous directed evolution to generate many diverse, functional TmTrpB sequences. TmTrpB variants are 
first evolved in replicate for Trp production in yeast. OrthoRep enables replicate evolution through error-prone replication of an orthogonal 
plasmid by an orthogonal polymerase, maintaining low error rates in genome replication. By encoding a TmTrpB variant on this plasmid 
in a tryptophan synthase (TRP5) deletion mutant, TmTrpB may be both continuously diversified and selected for through gradual 
reduction in Trp supplied in the growth medium. Evolved populations containing many diverse, functional individuals may then be 
randomly sampled and tested for activity with indole analogs. TmTrpB illustration generated using Illustrate.35 b, Selection trajectories for 
ten replicate cultures that evolved sufficient TmTrpB activity to support cell growth without supplemented Trp. Each point represents a 
single 1:100 dilution (passage) into fresh indole-supplemented growth medium. Trp concentration of fresh media was reduced when high 
saturation was achieved in the previous passage. Plots are slightly offset from true values to allow for visibility of all selection trajectories. 
Tm3C and Tm3D are plotted as one line as their trajectories were identical. c, TmTrpB homology model and table depicting consensus 
mutations of the ten cultures shown in panel b. Mutations are colored by their appearance in populations evolved from wt TmTrpB 
(yellow), TmTriple or TmTripleQ90* (green), or both (purple).  
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(Figs. 2 and Supplementary Fig. 2). Sixteen TmTrpB 
mutants were tested, representing one or two individual 
variants from each of the ten fully adapted populations. We 
found that 12 of the 16 TrpB variants complemented growth 
to a similar degree as TRP5 when supplemented with 400 
μM indole, demonstrating substantial improvement over 
their wt TmTrpB and TmTriple parents (Fig. 2a). 
 
Unsurprisingly, this set of clonal TmTrpBs contained more 
sequence diversity than the consensus sequences of the ten 
populations from which they were taken. Together, the 
variants tested comprised a total of 85 unique amino acid 
substitutions, with an average of 8.7 (± 2.1 s.d.) and a range 
of 5–13 non-synonymous mutations per variant (variant set 
1, Supplementary Tables 2 and 3). Since the 12 TmTrpBs 
from this set exhibiting complementation were all similarly 
active in their primary activity yet mutationally diverse (Fig. 
2b), we may conclude that our scaled evolution experiments 
generated substantial cryptic genetic variation. We note that 
four of 16 TmTrpB variants exhibited similar or lower Trp 
productivity compared to their parent (Supplementary Fig. 
2b). We suspect that the multicopy nature of p1 in the 
OrthoRep system allowed for deleterious mutations to be 
maintained for a period of time without experiencing 
purifying selection if they arose in the same cell as functional 
variants, explaining the presence of these low activity 
TmTrpBs. Indeed, this multicopy “buffering” may have 
worked to our advantage by promoting genetic drift under 
selection, facilitating both greater adaptation and greater 
diversity of evolutionary pathways across replicates (see 
Discussion). This may partly account for the high activity 
and high cryptic genetic variation present in the evolved 
TmTrpBs. 
 
 
Evolved TmTrpBs exhibit high primary and 
promiscuous activity in vitro 
 
We further characterized the evolved TmTrpBs in vitro to 
approximate conditions of industrial application, make 
kinetic measurements, and test whether promiscuous 
activity could be detected. Nine TmTrpB variants were 
sampled from those that supported robust indole-dependent 
growth in the Dtrp5 strain, cloned into an E. coli expression 
vector with a C-terminal polyhistidine tag, and 
overexpressed. To mimic streamlined purification conditions 
compatible with biocatalytic application of TmTrpBs, we 
generated heat-treated E. coli lysates and tested them for 
their ability to couple indole and serine to produce Trp at 30 
°C. Three of the nine OrthoRep-evolved TrpBs, C, D, and K, 
demonstrated improved activity over the benchmark 
TmTriple, as measured by total turnover number (TTN) 
(Supplementary Fig. 3). Conveniently, each of these 
variants was evolved from a different starting point, meaning 
that wt TmTrpB, TmTriple, and TmTripleQ90* were all viable 
starting points for reaching high activity TmTrpBs. 
 
Since the benchmark TmTriple against which we compared 
the evolved TmTrpBs was engineered through classical 
directed evolution involving screening E. coli lysates, 
whereas our TmTrpB variants were evolved in yeast but 
expressed in E. coli for characterization, it is likely that the 
high-activity evolved TmTrpBs would compare even more 
favorably if normalized by expression. We therefore purified 
C, D, and K by immobilized metal affinity chromatography 
(IMAC) and reevaluated their activity for coupling indole with 
serine to generate Trp. By TTN, all three variants showed a 
4- to 5-fold increase in activity over TmTriple at 30 °C 
(Supplementary Fig. 4a). At 75 °C, however, C had only ~2-
Fig. 2 | In vivo activity and diversity of 
individual TmTrpB variants from 
OrthoRep-evolved populations. a, 
Evaluation of TRP5 complementation by 
evolved variants through a growth rate 
assay. Maximum growth rates over a 24-
hour period for Δtrp5 yeast strains 
transformed with a nuclear plasmid 
expressing the indicated TmTrpB variant, 
grown in medium with or without 400 μM 
indole. Points and error bars represent 
mean ± s.d. for four biological replicates, 
respectively. Shaded area is the mean ± s.d. 
growth rate for the TRP5 positive control 
(i.e. plasmid expressing the endogenous 
yeast TRP5). Green box indicates the mean 
± s.d. growth rate for all strains shown when 
Trp is supplemented. b, Parent populations 
from which OrthoRep-evolved variants 
shown in a are derived and all non-
synonymous mutations present in each. 
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fold higher activity than TmTriple, while the other two 
variants were less active than TmTriple. Since the 
thermostability of C, D, and K had not been reduced 
dramatically (T50 > 83.7 °C, Supplementary Fig. 5), 
adaptation in C, D, and K occurred at least partially by 
shifting the activity temperature profile. This is a practically 
valuable adaptation, since thermostable enzymes that 
operate at mesophilic temperatures allow for greater 
versatility in application without sacrificing durability and 
ease of purification through heat treatment. 
 
Further testing of C, D, and K revealed that all three 
enzymes had at least a 22-fold higher kcat/KM for indole than 
did TmTriple at 30 °C (Supplementary Table 4 and 
Supplementary Fig. 6). Finally, testing for production of Trp 
analogs revealed that these variants’ improved performance 
with indole transferred to alternate substrates 
(Supplementary Fig. 4b), validating their utility as versatile 
biocatalysts and also the hypothesis that continuous 
evolution of TmTrpB variants can uncover promiscuous 
activities for which they were not selected. 
 
A diverse panel of evolved TmTrpB variants 
encompasses a variety of useful promiscuous 
activities with indole analogs 
 
Given the exceptional performance of C, D, and K and their 
ability to transfer primary activity to new substrates as 
promiscuous activity, we decided to further sample the 
variant diversity generated across the multiple TmTrpB 
evolution experiments. We cloned 60 randomly chosen 
TmTrpBs from the ten continuous evolution populations into 
E. coli expression vectors for in vitro characterization. These 
60 TmTrpBs represent extensive diversity, with an average 
of 9.3 (± 2.8 s.d.) non-synonymous mutations per variant 
and a total of 194 unique amino acid changes across the 
set; in addition, each sequence encoded a unique protein 
(variant set 2, Supplementary Tables 2 and 3). Since each  
variant had multiple non-synonymous mutations (up to 16) 
generated through >100 generations of adaptation and 
neutral drift, the depth of OrthoRep-based evolution was 
indeed leveraged in their evolution. We visualized these 
sequences, together with the consensus sequences of the 
populations from which they were derived, as nodes in a 
force directed graph related by shared mutations 
(Supplementary Fig. 7). With only one exception, all 
individual sequences cluster near the consensus sequence 
for their population, meaning that interpopulation diversity 
exceeded intrapopulation diversity. Thus, the scale of 
OrthoRep-based evolution was also leveraged in these 
variants — if fewer independent evolution experiments had 
been run, the reduction in diversity would not be recoverable 
from sampling more clones. 
 
Preparations of TmTrpBs C, D, and K, the 60 new variants, 
and four top-performing TrpB benchmark variants from past 
classical directed evolution campaigns (including TmTriple) 
were all tested for product formation with indole by UV 
absorption and nine indole analogs by high performance 
liquid chromatography-mass spectrometry (HPLC-MS) to 
detect substrate promiscuity (Fig. 3a). The panel of 63 
OrthoRep-evolved TmTrpB variants exhibited an impressive 
range of activities (Fig. 3b). First, we observed that a number 
of variants had primary activities with indole that surpass the 
benchmark TmTriple in lysate, with initial velocities of Trp 
formation up to 3-fold higher than C (Fig. 3b and 
Supplementary Fig. 8), whose kcat/KM for indole is 1.37 x 105 
M-1 s-1, already 28-fold higher than TmTriple’s at saturating 
serine concentrations (Supplementary Table 4 and 
Supplementary Fig. 6). Second, direct comparison of some 
of the best panel variants to TmTriple revealed dramatic 
general activity improvements for multiple indole analogs 
(Fig. 3b). For example, across the three most versatile 
variants (F7, D2, and F1) the maximum fold-improvement in 
product yields over TmTriple were 37, 5, 19, and 50 using 
substrates 5-cyanoindole (2), 7-cyanoindole (4), 5-
bromoindole (5), and 6-bromoindole (6), respectively (Fig. 
3c). Finally, with the exception of 6-bromoindole (6) and 
azulene (10), at least one variant from the OrthoRep-
evolved panel converted the indole analog substrates as 
well as or better than benchmark TrpBs Pf2B9, TmAzul, and 
Tm9D8*, which had been deliberately engineered toward 
new substrate scopes, though at higher temperatures (Figs. 
3b and Supplementary Figs. 8 and 9).7,21,25,26 
 
The diverse properties represented in our 63 variants were 
not just limited to primary activity increases on indole and 
promiscuous activities for indole analogs. Multiple variants 
from the panel also exhibited substantial improvements in 
selectivity for differently substituted indoles, which could be 
useful when working with substrate mixtures that may be 
less expensive to use industrially. For example, we 
observed many TmTrpBs with greater selectivity for 7-
bromoTrp over 5-bromoTrp as compared to all four of the 
benchmark engineered TrpBs (Fig. 3d). Another variant in 
the panel, G6, stood out for having appreciable activity with 
nearly all substrates tested, including 6-cyanoindole (3) and 
5-trifluoromethylindole (9), which are poorly utilized by most 
other TrpBs tested, likely due to electron-withdrawing effects 
of their respective moieties. Notably, the ability to accept 9 
as a substrate was unique to G6: all other variants, as well 
as the benchmark TrpBs, showed no detectable product 
formation with this substrate (Figs. 3e and Supplementary 
Fig. 9h). Repeating the reaction with purified enzyme 
validated the observed activity (Supplementary Fig. 10). G6 
may therefore be a promising starting point for new 
engineering efforts to access exotic Trp analogs. In short, 
despite having been selected for native activity with indole, 
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OrthoRep-evolved TmTrpBs have extensive and diverse 
activities on a range of non-native substrates, demonstrating  
the value of depth and scale in the evolution of enzyme 
variants. 
 
Mutations in evolved TmTrpBs may modulate 
conformational dynamics and fine tune the active site 
 
Of the ~200 unique mutations in the OrthoRep-evolved 
TmTrpBs that we characterized, there were some mutations 
whose effects could be rationalized from comparison to 
previous work. Since these TmTrpBs had to evolve stand-
alone activity, it is unsurprising that many of the mutations 
we observed have been implicated in the loss of allosteric 
regulation by TrpA. For example, Buller et al. previously 
examined a series of engineered variants from Pyrococcus 
furiosus TrpB (PfTrpB) and found that evolution for stand-
alone activity was facilitated by a progressive shift in the 
rate-limiting step from the first to the second stage of the 
catalytic cycle as well as stabilization of the ‘closed’ 
conformation of the enzyme.27 That work implicated eight 
residues in this mechanism, seven of which correspond to 
homologous sites where we observed mutations in the 
evolved TmTrpB variants (i.e., P14, M18, I69, K96, L274, 
T292, and T321). Another mutation, N167D, present in three 
of the ten consensus sequences for evolved populations 
(Fig. 1c), has also been implicated in stabilizing the closed 
state.21 Additional mutations observed but not studied 
before (e.g., S277F, S302P, and A321T) could also 
reasonably alter the allosteric network linking TmTrpB 
activity to its natural TmTrpA partner, based on existing 
structures and molecular dynamics simulations on the 
Fig. 3 | Promiscuous activities of a panel of evolved TmTrpBs. a, Indole substrates used to test the substrate scope of a panel of 
TmTrpB variants. 1, indole; 2, 5-cyanoindole; 3, 6-cyanoindole; 4, 7-cyanoindole; 5, 5-bromoindole; 6, 6-bromoindole; 7, 7-bromoindole; 
8, 5-methoxyindole; 9, 5-trifluoromethylindole; 10, azulene. b, Heatmap of TrpB activities reported as yield of the Trp analog produced 
from indicated substrates where 100% yield corresponds to full conversion of the indole analog to the Trp analog. Reactions were carried 
out using heat-treated cell lysate, yield was measured by HPLC-MS, and V0 is the initial rate of Trp formation from indole at saturating 
serine concentrations. Panel TmTrpB variants are ordered first by the parental cultures from which they were derived (shown above the 
heatmap), then by activity with indole. Reactions with OrthoRep-evolved variants other than C, D, and K were performed in one replicate 
and all other reactions performed in quadruplicate. Empty designates expression vector without any TrpB encoded. c, Bar graph of 
selected indole analog activities from panel b. Points represent % HPLC yield for individual replicates, bars represent mean yield for 
multiple replicates or yield for a single replicate. d, Activities of all variants shown in b for reactions with substrates 7 and 5 to show 
selectivity. Individual replicates are shown for empty vector and benchmark TrpBs and only mean values are shown for OrthoRep-evolved 
variants tested in replicate (i.e. C, D, and K) for clarity. e, Heat treated lysate activity with 9 for indicated TrpB variants. 
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homologous PfTrpA/PfTrpB complex.22,27 Taken together, 
these mutations are likely implicated in converting allosteric 
activation by TmTrpA into constitutive activity to establish 
stand-alone function of TmTrpBs. 
 
During the evolution of stand-alone activity, not only must 
allosteric activation by TmTrpA be recapitulated by 
mutations in TmTrpB, the surface of TmTrpB that normally 
interacts with TmTrpA must adjust to being exposed to 
solvent. Consistent with this adaptation, all consensus 
sequences for the ten successfully evolved populations from 
which our TmTrpB variants were sampled contain a 
mutation to at least one of a set of five residues located on 
the canonical TrpA interaction interface (Fig. 1c and 
Supplementary Fig. 11).  
 
We also detected strong convergent evolution in a region 
near the catalytic lysine, K83, which directly participates in 
TmTrpB’s catalytic cycle through covalent binding of PLP 
and multiple proton transfers (Supplementary Fig. 12).19 For 
example, A118 was mutated in the consensus sequence of 
four of the ten fully adapted populations, while adjacent 
residues T117 or A119 were mutated in an additional three 
(Fig. 1c). Furthermore, the three populations in which these 
residues were not mutated contained other consensus 
mutations that are either part of the α-helix to which K83 
belongs, or, like residues 117–119, within ~8 Å of this helix 
(Fig. 1c and Supplementary Fig. 12a). We hypothesize that 
the α-helix harboring K83 is a focal point of evolution, 
whereby mutations in its vicinity may finely adjust the 
positioning of K83 and the PLP cofactor to improve catalysis, 
perhaps as compensation for structural changes induced by 
thermoadaptation. Some OrthoRep-evolved variants also 
contained mutations to first- and second-shell active site 
residues (Supplementary Fig. 13), which may directly 
modulate the activity of TmTrpBs, although these mutations 
were rare. Taken together, we hypothesize that these 
mutations near the active site residues of TrpB were 
adaptive or compensatory. 
 
The ~20 mutations considered above are rationalized with 
respect to their impact on TmTrpB’s primary catalytic 
activity. While substrate promiscuity changes may be 
influenced by these explainable mutations, previous 
literature suggests that substrate specificity is globally 
encoded by amino acids distributed across an entire 
enzyme.28 Indeed, the majority of the ~200 mutations found 
in our panel of TmTrpBs were far away from TmTrpB’s 
active site and not rationalizable based on the known 
structural and kinetic properties of TrpBs. We suspect that 
the cryptic genetic variation this majority of mutations 
encompasses contributes to the diversity in substrate scope 
across our variants. 
 
Discussion 
 
In this work, we showed how the depth and scale of 
evolutionary search available in OrthoRep-driven protein 
evolution experiments could be applied to broaden the 
secondary promiscuous activities of TmTrpB while only 
selecting on its primary activity. The significance of this 
finding can be divided into two categories, one concerning 
the practical utility of the new TmTrpB variants we obtained 
and the second concerning how this evolution strategy may 
apply to future enzyme evolution campaigns and protein 
engineering in general. 
 
Practically, the new TmTrpBs should find immediate use in 
the synthesis of Trp analogs. Trp analogs are valuable chiral 
precursors to pharmaceuticals as well as versatile molecular 
probes, but their chemical synthesis is challenged by 
stereoselectivity requirements and functional group 
incompatibility. This has spurred enzyme engineers to 
evolve TrpB variants capable of producing Trp 
analogs,20,21,25,26 but the capabilities of available TrpBs are 
still limited. Compared to existing engineered TrpBs, our 
new panel of variants has substantially higher activity for the 
synthesis of Trp and Trp analogs at moderate temperatures 
from almost all indole analogs tested and also accepts 
indole analogs, such as 5-trifluoromethylindole, for which 
benchmark TrpBs used in this study showed no detectable 
activity (Fig. 3e). (In fact, only one TrpB variant has shown 
detectable activity for this substrate in previous classical 
directed evolution campaigns.21) In addition, at least one 
member of the panel accepted each of the nine indole 
analogs we used to profile promiscuity, suggesting that 
additional indole analogs and non-indole nucleophiles not 
assayed here will also be accepted as substrates.29,30 
Finally, the evolved TmTrpBs are both thermostable and 
adapted for enzymatic activity at 30 °C. This maximizes their 
industrial utility, as thermostability predicts a protein’s 
durability and can be exploited for simple heat-based 
purification processes, while mesophilic activity is 
compatible with heat-labile substrates, industrial processes 
where heating costs can compound, or in vivo applications 
in model mesophilic hosts (e.g. S. cerevisiae or E. coli). 
 
Of more general significance may be the process through 
which the TmTrpBs in this study were generated. Previous 
directed evolution campaigns aiming to expand the 
substrate scope of TrpB screened directly for activity on 
indole analogs to guide the evolution process,21,26 whereas 
this study only selected for TmTrpB’s primary activity on 
indole. Yet this study still yielded TmTrpBs whose 
secondary activities on indole analogs were both 
appreciable and diverse. Why? 
 
A partial explanation may come from the high primary 
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activities of OrthoRep-evolved TmTrpBs, as validated by 
kinetic measurements showing that variants tested have 
kcat/KM values for indole well in the 105 M-1 s-1 range. Since 
OrthoRep drove the evolution of TmTrpB in a continuous 
format for >100 generations, each resulting TmTrpB is the 
outcome of many rounds of evolutionary improvement and 
change (evolutionary depth). This contrasts with previous 
directed evolution campaigns using only a small number of 
manual rounds of diversification and screening. Continuous 
OrthoRep evolution, on the other hand, allowed TmTrpBs to 
become quite catalytically efficient with minimal researcher 
effort. We suggest that the high primary catalytic efficiencies 
also elevated secondary activities of TmTrpB, resulting in 
the efficient use of indole analogs. However, this 
explanation is not complete, as evolved TmTrpBs with 
similar primary activity on indole had differences in 
secondary activities (Fig. 3). In other words, high primary 
activities did not uniformly raise some intrinsic set of 
secondary activities in TmTrpB, but rather influenced if not 
augmented the secondary activities of TmTrpB in different 
ways. We attribute this to the fact that we ran our evolution 
experiments in multiple independent replicates (evolutionary 
scale). Each replicate could therefore evolve the same 
primary activity through different mutational paths, the 
idiosyncrasies of which manifest as distinct secondary 
activities. A third explanation for the promiscuous profile 
diversity of these TmTrpB variants is that each replicate 
evolution experiment had, embedded within it, mechanisms 
to generate cryptic genetic variation without strong selection 
on primary activity. Many of the clones we sampled from 
each TmTrpB evolution experiment had novel promiscuity 
profiles but mediocre primary activity with indole (Fig. 3). We 
believe this is because OrthoRep drove TmTrpB evolution 
in the context of a multicopy plasmid such that non-neutral 
genetic drift from high activity sequences could occur within 
each cell at any given point. Therefore, TmTrpB sequences 
with fitness-lowering mutations could persist for short 
periods of time, potentially allowing for the crossing of fitness 
valleys during evolution experiments and, at the end of each 
evolution experiment, a broadening of the genetic diversity 
of clones even without explicitly imposed periods of relaxed 
selection. Since enzyme orthologs are capable of 
specializing towards different sets of secondary activities 
when pressured to do so,2,3 non-neutral genetic drift from 
different consensus sequences across independent 
population should also access different secondary activities, 
further explaining the diversity of promiscuous activity 
profiles across clones selected from replicate evolution 
experiments. The combination of these mechanisms likely 
explains the variety of properties encompassed by the panel 
of TmTrpBs. 
 
Our approach to TmTrpB evolution was inspired by the idea 
of gene orthologs in nature. Orthologs typically maintain 
their primary function while diversifying promiscuous 
activities through long evolutionary histories in different 
species.2,31 We approximated this by evolving TmTrpB 
through continuous rounds of evolution, mimicking long 
histories, and in multiple replicates, mimicking the spatial 
separation and independence of species. Such depth and 
scale of evolutionary search is likely responsible for the 
substrate scope diversity of the TmTrpBs we report even as 
they were selected only on their primary activity. We 
recognize that the evolved TmTrpBs represent lower 
diversity than natural orthologs. For example, the median 
amino acid sequence divergence between orthologous 
human and mouse proteins is 11%,32 while the median 
divergence between pairs of variants from our experiment is 
4.3% with a maximum of 8% (Supplementary Fig. 14). Still, 
this level of divergence between functional variants is 
substantial for a laboratory protein evolution experiment and 
suggests that it is realistic to model future work on the 
processes of natural ortholog evolution (Fig. 4). For 
example, it should be straightforward to scale our 
experiments further, to hundreds or thousands of 
Fig. 4 | Conceptual similarities between natural enzyme 
ortholog evolution and OrthoRep evolution. Splitting OrthoRep 
cultures into many replicates can be seen as a form of speciation 
occurring by spatial separation. Complex selection schedules may 
emulate varied selection histories of natural orthologs, generating 
substantial sequence divergence across replicates. Evolved 
OrthoRep cultures contain diverse populations of sequences akin 
to quasispecies owing to high mutation rates.36 
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independent populations each evolving over longer periods 
of time. This would better simulate the vastness of natural 
evolution. It should also be possible to deliberately vary 
selection schedules by adding competitive TmTrpB 
inhibitors (such as the very indole analogs for which they 
have promiscuous activity), changing temperatures, or 
cycling through periods of weak and strong selection at 
different rates. Such evolutionary courses would 
approximate complexity in natural evolutionary histories. 
These modifications to OrthoRep-driven TmTrpB evolution 
should yield greater cryptic genetic diversity, which may 
result in further broadening of promiscuous functions. The 
generation of cryptic genetic diversity at depth and scale 
should also be useful in efforts to predict protein folding and 
the functional effects of mutations via co-evolutionary 
analysis.33,34 Indeed, catalogs of natural orthologs have 
proven highly effective in fueling such computational efforts, 
so our ability to mimic natural ortholog generation on 
laboratory timescales may be applicable to protein biology 
at large. Within the scope of enzyme engineering, we 
envision that the process of continuous replicate evolution, 
selecting only on primary activities of enzymes, will become 
a general strategy for expanding promiscuous activity 
ranges of enzymes as we and others extend it to new 
targets.
 
Acknowledgments 
This work was funded by NIH NIGMS (1DP2GM119163-01), NSF 
(MCB 1545158), and the Beckman Young Investigator Award to 
C.C.L., and the NIH NIGMS (R01GM125887) to F.H.A. The content 
is solely the responsibility of the authors and does not necessarily 
represent the official views of funding sources. We thank David 
Romney, Justin Bois, and other members of the Arnold and Liu 
groups for thoughtful discussions on experimental design. 
 
Author Contributions 
All authors contributed to experimental design and data analysis. 
G.R. cloned all genetic constructs; set up, performed, and 
characterized evolution experiments; and carried out yeast growth 
rate experiments. E.J.W. performed the panel HPLC-MS assay 
and indole conversion rate measurements on TmTrpBs from 
variant set 2, and P.J.A. analyzed the results. C.E.B. performed in 
vitro characterizations of TmTrpBs from variant set 1 and 
performed the thermal shift assay and substrate scope 
characterizations for TmTrpB variants C, D, and K. P.J.A. 
performed enzyme kinetics assays for TmTrpB variants C, D, and 
K. G.R. and C.C.L. wrote the manuscript with input and 
contributions from all authors. 
 
Competing interests 
C.E.B. and F.H.A. are co-founders of Aralez Bio, focusing on the 
enzymatic synthesis of unnatural amino acids. 
 
Author information 
Christina E. Boville 
Present address: Aralez Bio, Emeryville, CA, USA 
 
Affiliations 
Department of Molecular Biology and Biochemistry, University of 
California, Irvine, Irvine, CA, USA 
Gordon Rix, Chang C. Liu 
 
Department of Biomedical Engineering, University of California, 
Irvine, Irvine, CA, USA 
Chang C. Liu 
 
Department of Chemistry, University of California, Irvine, Irvine, 
CA, USA 
Chang C. Liu 
 
Division of Biology and Biological Engineering, California Institute 
of Technology, Pasadena, CA, USA 
Ella J. Watkins-Dulaney, Frances H. Arnold 
 
Division of Chemistry and Chemical Engineering, California 
Institute of Technology, Pasadena, CA, USA 
Patrick J. Almhjell, Frances H. Arnold 
 
Corresponding author 
Correspondence to Chang C. Liu 
 
References 
 
1. Tatusov, R. L., Koonin, E. V. & Lipman, D. J. A genomic 
perspective on protein families. Science. 278, 631–637 
(1997). 
2. Khanal, A., McLoughlin, S. Y., Kershner, J. P. & Copley, S. 
D. Differential Effects of a Mutation on the Normal and 
Promiscuous Activities of Orthologs: Implications for 
Natural and Directed Evolution. Mol. Biol. Evol. 32, 100–
108 (2015). 
3. Baier, F. et al. Cryptic genetic variation shapes the 
adaptive evolutionary potential of enzymes. Elife 8, 1–20 
(2019). 
4. Aharoni, A. et al. The ‘evolvability’ of promiscuous protein 
functions. Nat. Genet. 37, 73–76 (2005). 
5. Tawfik, O. K. and D. S. Enzyme Promiscuity: A 
Mechanistic and Evolutionary Perspective. Annu. Rev. 
Biochem. 79, 471–505 (2010). 
6. Leveson-Gower, R. B., Mayer, C. & Roelfes, G. The 
importance of catalytic promiscuity for enzyme design and 
evolution. Nat. Rev. Chem. 3, 687–705 (2019). 
7. Murciano-Calles, J., Romney, D. K., Brinkmann-Chen, S., 
Buller, A. R. & Arnold, F. H. A Panel of TrpB Biocatalysts 
Derived from Tryptophan Synthase through the Transfer of 
Mutations that Mimic Allosteric Activation. Angew. Chemie 
- Int. Ed. 55, 11577–11581 (2016). 
8. Devine, P. N. et al. Extending the application of 
biocatalysis to meet the challenges of drug development. 
Nat. Rev. Chem. 2, 409–421 (2018). 
9. Truppo, M. D. Biocatalysis in the Pharmaceutical Industry: 
The Need for Speed. ACS Med. Chem. Lett. 8, 476–480 
(2017). 
10. Almhjell, P. J., Boville, C. E. & Arnold, F. H. Engineering 
enzymes for noncanonical amino acid synthesis. Chem. 
Soc. Rev. 47, 8980–8997 (2018). 
11. Zheng, J., Payne, J. L. & Wagner, A. Cryptic genetic 
variation accelerates evolution by opening access to 
diverse adaptive peaks. Science. 365, 347–353 (2019). 
was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 
The copyright holder for this preprint (whichthis version posted June 2, 2020. . https://doi.org/10.1101/2020.06.01.128165doi: bioRxiv preprint 
12. Gupta, R. D. & Tawfik, D. S. Directed enzyme evolution via 
small and effective neutral drift libraries. 5, 939–942 
(2008). 
13. Bloom, J. D., Romero, P. A., Lu, Z. & Arnold, F. H. Neutral 
genetic drift can alter promiscuous protein functions, 
potentially aiding functional evolution. Biol. Direct 2, 7–10 
(2007). 
14. Bershtein, S., Goldin, K. & Tawfik, D. S. Intense Neutral 
Drifts Yield Robust and Evolvable Consensus Proteins. J. 
Mol. Biol. 379, 1029–1044 (2008). 
15. Ravikumar, A., Arrieta, A. & Liu, C. C. An orthogonal DNA 
replication system in yeast. Nat. Chem. Biol. 10, 175–177 
(2014). 
16. Ravikumar, A. et al. Scalable , Continuous Evolution of 
Genes at Mutation Rates above Genomic Error Thresholds 
Resource Scalable , Continuous Evolution of Genes at 
Mutation Rates above Genomic Error Thresholds. Cell 
175, 1946-1957.e13 (2018). 
17. Packer, M. S. & Liu, D. R. Methods for the directed 
evolution of proteins. Nat. Rev. Genet. 16, 379–394 
(2015). 
18. Zhong, Z. et al. Automated continuous evolution of proteins 
in vivo. ACS Synth. Biol. 2020.02.21.960328 (2020). 
doi:10.1021/acssynbio.0c00135 
19. Dunn, M. F. Allosteric regulation of substrate channeling 
and catalysis in the tryptophan synthase bienzyme 
complex. Arch. Biochem. Biophys. 519, 154–166 (2012). 
20. Buller, A. R. et al. Directed evolution of the tryptophan 
synthase β-subunit for stand-alone function recapitulates 
allosteric activation. Proc. Natl. Acad. Sci. 112, 14599–
14604 (2015). 
21. Romney, D. K., Murciano-Calles, J., Wehrmüller, J. E. & 
Arnold, F. H. Unlocking Reactivity of TrpB: A General 
Biocatalytic Platform for Synthesis of Tryptophan 
Analogues. J. Am. Chem. Soc. 139, 10769–10776 (2017). 
22. Maria-Solano, M. A., Iglesias-Fernández, J. & Osuna, S. 
Deciphering the Allosterically Driven Conformational 
Ensemble in Tryptophan Synthase Evolution. J. Am. 
Chem. Soc. 141, 13049–13056 (2019). 
23. Zhong, Z., Ravikumar, A. & Liu, C. C. Tunable Expression 
Systems for Orthogonal DNA Replication. ACS Synth. Biol. 
7, 2930–2934 (2018). 
24. Lee, M. E., DeLoache, W. C., Cervantes, B. & Dueber, J. 
E. A Highly Characterized Yeast Toolkit for Modular, 
Multipart Assembly. ACS Synth. Biol. 4, 975–986 (2015). 
25. Watkins, E. J., Almhjell, P. J. & Arnold, F. H. Direct 
Enzymatic Synthesis of a Deep-Blue Fluorescent 
Noncanonical Amino Acid from Azulene and Serine. 
ChemBioChem 21, 80–83 (2020). 
26. Boville, C. E., Romney, D. K., Almhjell, P. J., Sieben, M. & 
Arnold, F. H. Improved Synthesis of 4-Cyanotryptophan 
and Other Tryptophan Analogues in Aqueous Solvent 
Using Variants of TrpB from Thermotoga maritima. J. Org. 
Chem. 83, 7447–7452 (2018). 
27. Buller, A. R. et al. Directed Evolution Mimics Allosteric 
Activation by Stepwise Tuning of the Conformational 
Ensemble. J. Am. Chem. Soc. 140, 7256–7266 (2018). 
28. Wrenbeck, E. E., Azouz, L. R. & Whitehead, T. A. Single-
mutation fitness landscapes for an enzyme on multiple 
substrates reveal specificity is globally encoded. Nat. 
Commun. 8, 1–10 (2017). 
29. Dick, M., Sarai, N. S., Martynowycz, M. W., Gonen, T. & 
Arnold, F. H. Tailoring Tryptophan Synthase TrpB for 
Selective Quaternary Carbon Bond Formation. J. Am. 
Chem. Soc. 141, 19817–19822 (2019). 
30. Romney, D. K., Sarai, N. S. & Arnold, F. H. Nitroalkanes as 
Versatile Nucleophiles for Enzymatic Synthesis of 
Noncanonical Amino Acids. ACS Catal. 9, 8726–8730 
(2019). 
31. O’Maille, P. E. et al. Quantitative exploration of the 
catalytic landscape separating divergent plant 
sesquiterpene synthases. Nat. Chem. Biol. 4, 617–623 
(2008). 
32. Makałowski, W. & Boguski, M. S. Evolutionary parameters 
of the transcribed mammalian genome: An analysis of 
2,820 orthologous rodent and human sequences. Proc. 
Natl. Acad. Sci. U. S. A. 95, 9407–9412 (1998). 
33. Marks, D. S. et al. Protein 3D structure computed from 
evolutionary sequence variation. PLoS One 6, (2011). 
34. Stiffler, M. A. et al. Protein Structure from Experimental 
Evolution. Cell Syst. 10, 15-24.e5 (2020). 
35. Goodsell, D. S., Autin, L. & Olson, A. J. Illustrate: Software 
for Biomolecular Illustration. Structure 27, 1716-1720.e1 
(2019). 
36. Eigen, M., McCaskill, J. & Schuster, P. Molecular quasi-
species. J. Phys. Chem. 92, 6881–6891 (1988). 
37. Gibson, D. G. et al. Enzymatic assembly of DNA molecules 
up to several hundred kilobases. Nat. Methods 6, 343–345 
(2009). 
38. Gietz, R. D. & Schiestl, R. H. High-efficiency yeast 
transformation using the LiAc/SS carrier DNA/PEG 
method. Nat. Protoc. 2, 31–34 (2007). 
39. Ryan, O. W. & Cate, J. H. D. Multiplex engineering of 
industrial yeast genomes using CRISPRm. Methods in 
Enzymology 546, (Elsevier Inc., 2014). 
40. Jung, P. P., Christian, N., Kay, D. P., Skupin, A. & Linster, 
C. L. Protocols and programs for high-throughput growth 
and aging phenotyping in yeast. PLoS One 10, (2015). 
41. Lane, A. N. & Kirschner, K. The Catalytic Mechanism of 
Tryptophan Synthase from Escherichia coli. Eur. J. 
Biochem. 129, 571–582 (1983). 
 
  
was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 
The copyright holder for this preprint (whichthis version posted June 2, 2020. . https://doi.org/10.1101/2020.06.01.128165doi: bioRxiv preprint 
Materials and methods 
 
DNA plasmid construction 
  
Plasmids used in this study are listed in Supplementary Table 5. All plasmids that were not generated in a 
previous study were constructed via Gibson assembly37 from parts derived from the Yeast Toolkit,24 from 
previously described OrthoRep integration cassette plasmids,16 from E. coli expression vectors for previously 
described TrpB variants,7,26 from synthesized oligonucleotides, from yeast genomic DNA, or from the standard 
E. coli expression vector, pET-22b(+). All DNA cloning steps and E. coli protein expression steps were performed 
in E. coli strains TOP10 and BL21(DE3), respectively. All oligonucleotides used for PCR were purchased from 
IDT, and all enzymes and reagents used for cloning were purchased from NEB. 
 
Parts used to generate yeast nuclear expression plasmids for testing the selection and p1 integration plasmids 
were PCR amplified from DNA sources listed above, Gibson assembled, transformed into E. coli, and plated 
onto selective LB agar plates. Individual clones were picked, grown to saturation in selective LB liquid media, 
miniprepped, and sequence confirmed. Following evolution of TrpB, individual variants were assembled into new 
yeast or E. coli expression vectors through PCR amplification of purified DNA from evolved yeast cultures, bulk 
cloning into the appropriate expression vector, picking individual colonies, and confirming absence of any 
frameshift mutations by Sanger sequencing. 
 
Yeast strains and media 
 
All yeast strains used in this study are listed in Supplementary Table 6. Yeast were incubated at 30 °C, with 
shaking at 200 rpm for liquid cultures, and were typically grown in synthetic complete (SC) growth medium (20 
g/L dextrose, 6.7 g/L yeast nitrogen base w/o amino acids (US Biological), 2 g/L SC dropout (US Biological) 
minus nutrients required for appropriate auxotrophy selection(s)), or were grown in YPD growth medium (10 g/L 
bacto yeast extract, 20 g/L bacto peptone, 20 g/L dextrose) with or without antibiotics, if no auxotrophic markers 
were being selected for. Media agar plates were made by combining 2X concentrate of molten agar and 2X 
concentrate of desired media formulation. Prior to all experiments, cells were grown to saturation in media 
selecting for maintenance of any plasmids present. 
 
Yeast transformation 
 
All yeast transformations were performed as described in Gietz and Shiestl.38 After all transformations, 
transformed cells were streaked onto selective media agar plates, and resulting single colonies were picked for 
all further uses. Transformations for integration onto p1 were performed as described previously:15 2–4 µg of 
plasmid DNA with ScaI restriction sites adjacent to integration flanks was cut with ScaI-HF (NEB) and 
transformed into yeast harboring the wt p1 and p2 plasmids. Proper integration was validated by miniprepping 
resulting clonal strain as previously described,15 visualizing the recombinant p1 band of the desired size by gel 
electrophoresis, and PCR and Sanger sequencing of the gene of interest integrated onto p1. Resulting strains 
were then transformed with either of two plasmids for nuclear expression of an OrthoRep terminal protein DNA 
polymerase 1 (TP-DNAP1) variant: wt TP-DNAP1 (pAR-Ec318) for evaluating trp5 complementation of TrpB 
variants without mutagenesis, or error-prone TP-DNAP1 (pAR-Ec633) for generating strains ready for TrpB 
evolution. These strains were passaged for ~40 generations in order to stabilize copy number of the recombinant 
p1 species, prior to any use in experiments. 
 
Genomic deletions were made through co-transformation of a CRISPR/Cas9 plasmid targeting the region of 
interest and a linear DNA fragment comprised of two concatenated 50 bp homology flanks to the region of 
interest.39 Transformations were then plated on selective media agar, colonies were re-streaked onto 
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nonselective media agar, and resulting colonies were grown to saturation in liquid media. The region of interest 
was PCR amplified and Sanger sequenced to confirm presence of desired modification. 
 
Plating assays 
 
Yeast strains expressing a TrpB variant either from a nuclear plasmid, or from p1, with wt OrthoRep polymerase 
(TP-DNAP1) expressed from a nuclear plasmid, were grown to saturation in SC –L or SC –LH, spun down, 
washed once with 0.9% NaCl, then spun down again, and the resulting pellet was resuspended in 0.9% NaCl. 
Washed cells were then diluted 1:100 in 0.9% NaCl, and 10 µL of each diluted cell suspension was plated onto 
media agar plates in pre-marked positions. After 3 days of growth, cell spots were imaged (Bio-Rad 
ChemiDoc™). Resulting images were adjusted uniformly (‘High’ set to 40,000) to improve visibility of growth 
(Bio-Rad Image Lab™ Software). Figures utilizing these images (Supplementary Figs. 1 and 2a) were made by 
manually combining images of different plates, but all images of the same media condition within each figure 
panel were derived from the same image of a single plate. 
 
TmTrpB evolution 
 
Yeast strains with a nuclear plasmid expressing error-prone TP-DNAP1 and with wt TmTrpB, TmTriple, or 
TmTripleQ90* encoded on p1 (GR-Y053, GR-Y055, and GR-Y057, Supplementary Table 6) were grown to 
saturation in SC –LH, prior to passaging for evolution. All cultures passaged for evolution of TmTrpB regardless 
of success are described in Supplementary Table 1. To provide enough indole substrate for sufficient Trp 
production, but not enough to induce toxicity, all growth media used for evolution of TrpB activity was 
supplemented with 100 μM indole, as informed by results shown in Supplementary Fig. 1a. All passages for 
evolution were carried out as 1:100 dilutions. In order to induce a growth defect but still allow for some growth, 
the first passage for each evolution culture was carried out in SC –LH media with 37 µM Trp (7.6 mg/L). After 
two or three days of shaking incubation, if OD600 > 1.0 (Bio-Rad SmartSpec™ 3000) for 100 mL cultures, or if 
most wells in a 24 well block of 3 mL cultures were saturated to a similar degree by eye, cultures were passaged 
into fresh growth medium with a slightly reduced Trp concentration. If the level of growth was beneath this 
threshold, the culture was passaged into growth medium with the same Trp concentration. This process was 
continued until a Trp concentration of 3.7 µM was reached, at which point a passage into media lacking Trp was 
attempted, which typically resulted in successful growth. Resulting cultures were then passaged six additional 
times into growth medium lacking Trp. 
 
Growth rate assays 
 
Yeast strains containing nuclear plasmids encoding one of several OrthoRep-evolved TrpB variants, wt TmTrpB, 
TmTriple, or none of these (denoted ‘empty’) were grown to saturation in SC –L, washed as described above, 
then inoculated 1:100 into multiple media conditions in 96-well clear bottom plates, with four biological replicates 
per media/strain combination. Plates were then sealed with a porous membrane and allowed to incubate with 
shaking at 30 °C for 24 hours, with OD600 measurements taken automatically every 30 minutes (Tecan Infinite 
M200 Pro), according to a previously described protocol.40 Multiple 24 hour periods were required for each 
experiment, but empty controls were included in each individual 96-well plate to ensure validity of growth in other 
cultures. Raw OD600 measurements were fed into a custom MATLAB script,18 which carries out a logarithmic 
transformation to linearize the exponential growth phase, identifies this growth phase, and uses this to calculate 
the doubling time (T). Doubling time was then converted to growth rate by the equation ln(2)/T. 
 
Enzyme characterization — general experimental methods 
 
Chemicals and reagents were purchased from commercial sources and used without further purification. All 
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cultures were grown in Terrific Broth supplemented with 100 μg/mL carbenicillin (TBcarb). Cultures were shaken 
in a New Brunswick Innova 4000 (shaking diameter 19 mm), with the exception of the 96-well deep-well 
plates (USA Scientific), which were shaken in a Multitron INFORS HT (shaking diameter 50 mm). Lysis buffer 
was composed of 50 mM potassium phosphate, pH 8.0 (KPi buffer), supplemented with 100 or 200 µM pyridoxal 
5’-phosphate (PLP). Heat lysis was performed in a 75 °C water bath (Fisher) for >1 hour. Protein concentrations 
were determined using a Pierce™ BCA Protein Assay Kit (Thermo Scientific). Reactions were performed in KPi 
buffer. Liquid chromatography/mass spectrometry (LCMS) was performed on an Agilent 1290 UPLC-LCMS 
equipped with a C-18 silica column (1.8 μm, 2.1 × 50 mm) using CH3CN/H2O (0.1% acetic acid by volume): 5% 
to 95% CH3CN over 2 min; 1 mL/min. Liquid chromatography/mass spectrometry (LCMS) was also performed 
on an Agilent 1260 HPLC-MS equipped with Agilent InfinityLab Poroshell 120 EC-C18 column (2.7 μm, 4.6×50 
mm): hold 5% CH3CN for 0.5 min, 5-95% CH3CN over 2 min; 1 mL/min. 
 
TrpB variants selected for further characterization were cloned into a pET-22b(+) vector with a C-terminal 6X 
His-tag and transformed into E. coli BL21(DE3) cells (Lucigen).  
 
Expression and characterization of variants from set 1 — large scale expression and lysis 
 
A single colony containing the appropriate TrpB gene was used to inoculate 5 mL TBcarb and incubated overnight 
at 37 °C and 230 rpm. For expression, 0.5 mL of overnight culture were used to inoculate 50 mL TBcarb in a 250 
mL flask and incubated at 37 °C and 250 rpm for 3 hours to reach OD600 0.6–0.8. Cultures were chilled on ice 
for 20 min and expression was induced with a final concentration of 1 mM isopropyl β-D-
thiogalactopyranoside (IPTG). Expression proceeded at 25 °C and 250 rpm for approximately 20 hours. Cells 
were harvested by centrifugation at 5,000g for 5 min at 4 °C, and then the supernatant was decanted. The pellet 
was stored at −20 °C until further use or used immediately for whole cell transformations. 
 
Pellets were lysed in 5 mL of lysis KPi buffer with 200 μM PLP, supplemented with 1 mg/mL lysozyme (HEWL, 
Sigma Aldrich), 0.02 mg/mL bovine pancreas DNase I, and 0.1X BugBuster (Novagen) and incubated at 37 °C 
for 30 minutes. Lysate was clarified by centrifugation at 5,000g for 10 min, divided into 1 mL aliquots, and stored 
at −20 °C until further use.  
 
Expression and characterization of variants from set 1 — lysate and whole cell small-scale reactions 
 
Protein concentration in lysate was quantified by BCA. Lysate reactions were performed in 2 mL glass HPLC 
vials (Agilent) charged with indole (final conc. 20 mM) dissolved in DMSO (5% w/v), followed by the addition 
of lysate (final enzyme conc. 4 μM), and serine (final conc. 20 mM) to achieve a final volume of 200 μL. Whole 
cell reactions were performed in 2 mL glass HPLC vials (Agilent) charged with indole (final conc. 20 mM) 
dissolved in DMSO (5% w/v), followed by the addition of cells diluted in KPi buffer (final OD600=6), and serine 
(final conc. 20 mM) to achieve a final volume of 200 μL. Reactions were incubated at 30 °C for 24 hours, diluted 
with 800 μL 1:1 CH3CN/1 M aq. HCl, and analyzed via UHPLC-MS. 
 
Expression and characterization of variants from set 1 — thermostability determination 
 
Enzyme T50 measurements (the temperature at which 50% of the enzyme is irreversibly inactivated after a 1 
hour incubation) were used to report on the thermostability of the enzyme. In a total volume of 100 µL, samples 
were prepared in KPi buffer with 1 µM enzyme in PCR tubes and either set aside (25 °C) or heated in a thermal 
cycler on a gradient from 79–99 °C (OrthoRep-generated variants), or 59–99 °C (TmTriple), for 1 hour, with each 
temperature performed in duplicate. Precipitated protein was pelleted via centrifugation and 75 µL of each 
sample was carefully removed and added to the wells of a 96-well UV-transparent assay plate containing 0.5 
mM indole and 0.5 mM serine. Relative product formation was observed by measuring the change in absorbance 
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at 290 nm to determine the temperature at which the sample had 50% residual activity compared to the 25 °C 
samples (modeled as a logistic function).  
 
Expression and characterization of variants from set 1 — enzyme kinetics 
 
Enzymatic parameters, kcat and KM, for the conversion of indole to Trp were estimated via Bayesian inference 
(pystan 2.19.0.0) assuming Michaelis-Menten behavior under saturating serine (40 mM) in KPi buffer. Briefly, 
initial velocities (v) were determined by monitoring Trp formation in a Shimadzu UV-1800 spectrophotometer at 
30 °C for 1 min over a range of indole concentrations at 290 nm using the reported indole-Trp difference in 
absorbance coefficient (∆ε290 = 1.89 mM-1 cm-1).41 These velocities were modeled using the equation:  
 𝑣 = 	 𝑉!"#[indole]𝐾$ + [indole] 
 
and estimates for v and Vmax were converted to k and kcat by normalizing for enzyme concentration. Parameter 
estimates are obtained as Hamiltonian Markov chain Monte Carlo (MCMC) posterior samples and reported as 
the median with their 95% credible regions (CR). The code used to generate these estimates (along with example 
data) can be found at http://github.com/palmhjell/bayesian_kinetics. 
  
Expression and characterization of variants from set 2 — small-scale expression and lysis 
 
Variants were arrayed into a 96-well deep-well plate along with TmTriple, Tm9D8*, TmAzul, and Pf2B9. 
Individual colonies were grown in 600 μL TBcarb in 96-well polypropylene plates overnight at 37 °C, 250 rpm, 80% 
humidity. The following day, 20 μL of overnight culture was used to inoculate 630 μL TBcarb in deep-well 96-well 
plates and grown at 37 °C, 250 rpm. After 4 hours, cultures were chilled on ice for 20–30 min and protein 
expression was induced with 50 μL IPTG (final conc. 1 mM) diluted in TBcarb. Cultures were shaken at 20 °C, 
250 rpm for 20–24 hours, after which they were subjected to centrifugation at 5,000g for 10 min. The cell 
pellets were frozen at −20 °C until further use or used immediately. 
 
Expression and characterization of variants from set 2 — indole rate measurements 
 
Pellets were lysed in either 600 μL of KPi buffer with 100 μM PLP and heat-treated at 75 °C for 1 hour, or in 
600 μL of this buffer supplemented with 1 mg/mL lysozyme, 0.02 mg/mL bovine pancreas DNase I, 
and 0.1X BugBuster and incubated at 37 °C for 1 hour. Lysate from both conditions was clarified by 
centrifugation at 4,500g for 10 min and stored at 4 °C until further use. 
 
Reaction master mix composed of 625 μM indole and 25 mM serine in KPi buffer was prepared and, before 
reactions, plates and master mix were incubated in 30 °C water bath for 30 min. The microplate reader (Tecan 
Spark) was also pre-heated to 30 °C. 
 
To UV-transparent 96-well assay plates (Caplugs, catalog # 290-8120-0AF), 160 μL pre-heated reaction master 
mix was added by 12-channel pipet followed by 40 μL of lysate from the pre-heated plate using a Microlab 
NIMBUS96 liquid handler (Hamilton). Plates were immediately transferred into the plate reader, shaken for 10 
sec to mix and the absorbance of each well at 290 nm was recorded as rapidly as possible (~20 
sec between measurements) for 120 cycles. The rate of product formation was determined by finding the rate of 
absorbance change over time and converting to units of concentration using ∆ε290 = 1.89 mM-1 cm-1 (see 
above) and a determined path length of 0.56 cm. Differences between the two lysate preparations were not 
significant suggesting that most enzyme variants retained sufficient thermostability for purification via heat 
treatment, and this method was used in subsequent experiments. 
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Expression and characterization of variants from set 2 — substrate scope screen 
 
Pellets were lysed in 300 μL KPi buffer with 200 μM PLP and clarified by centrifugation at 4,000g for 10 min. To 
a 96-well deep-well plate charged with 10 μL nucleophile dissolved in DMSO (final conc. denoted in the table 
directly below), 40 μL of the heat-treated lysate was transferred using a Microlab NIMBUS96 liquid handler 
(Hamilton), followed by addition of 150 μL serine (final conc. 20 mM) with a 12-channel pipet. Reactions were 
sealed with 96-well ArctiSeal™ Silicone/PTFE Coating (Arctic White) and incubated in 30 °C water bath for ~24 
hours. Reactions were diluted with 600 μL 2:1 CH3CN/1 M aq. HCl, subjected to centrifugation at 5,000g, and 
400 μL was transferred to 2 mL glass HPLC vials (Agilent). Samples were analyzed by HPLC-MS. Azulene 
samples were further diluted 20X to avoid oversaturation of the UV-detector and analyzed via UHPLC-MS. 
 
Nucleophile  Source  Catalog #  CAS  Final conc. 
(mM)  
5-Trifluoromethylindole  Sigma  701068  100846-24-0  10  
4-Cyanoindole  Sigma  645532  100846-24-0  20  
5-Cyanoindole  Chem Impex  21849  15861-24-2  20  
6-Cyanoindole  Chem Impex  21181  15861-36-6  20  
7-Cyanoindole  Sigma  CDS008484  
 
20  
5-Bromoindole  Sigma  B68607  10075-50-0  20  
5-Methoxyindole  Combi-Blocks  IN0049  1006-94-6  20  
Azulene  Alfa Aesar  L08271  275-51-4  20  
 
All samples except those containing azulene were analyzed at 277 nm, representing the isosbestic point 
between indole and Trp and allowing estimation of yield by comparing the substrate and product peak areas for 
indole analogs.21 Azulene yield was estimated as described previously.25 Nucleophile retention times were 
determined though injection of authentic standards and product retention times were identified by extracting their 
expected mass from the mass spectrum. 
 
Large-scale expression and purification of B5 and G6 
 
A single colony containing the appropriate TrpB gene was used to inoculate 5 mL TBcarb and incubated overnight 
at 37 °C and 230 rpm. For expression, 2.5 mL of overnight culture were used to inoculate 250 mL TBcarb in a 1-
L flask and incubated at 37 °C and 250 rpm for 3 hours to reach OD600 0.6–0.8. Cultures were chilled on ice for 
20 min and expression was induced with a final concentration of 1 mM IPTG. Expression proceeded at 25 °C 
and 250 rpm for approximately 20 hours. Cells were harvested by centrifugation at 5,000g for 5 min at 4 °C, and 
then the supernatant was decanted. The pellet was stored at −20 °C until further use. 
 
Pellets were lysed in 25 mL KPi buffer with 200 μM PLP for >1 hour at 75 °C. Lysate was clarified by spinning 
14,000g for 20 min at 4 °C (New Brunswick Avanti J-30I). Protein was purified over hand-packed HisPur™ Ni-
NTA Resin (Thermo Scientific, catalog # 88221), dialyzed into KPi buffer and quantified by BCA.  
 
B5 PLP-binding assay 
 
Variant B5 did not the exhibit characteristic yellow color of PLP-bound TrpB variants after purification, however 
BCA indicated comparable protein concentrations to the G6 variant. We have previously observed that 
some TrpB variants lose binding affinity for PLP resulting in non-functional apoenzyme. We evaluated Trp 
formation of B5 supplemented with 0, 0.1, 0.25, 0.5, 1, 2, 5, and 100 μM PLP via UV-Vis 
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spectrophotometry. Serine (final conc. 25 mM) + PLP master mixes of the eight concentrations were prepared 
and dispensed into 96-well UV-transparent plate. Enzyme (final conc. 1 μM) with or without indole master mixes 
were prepared and 100 µL dispensed into 96-well plate. The plate was immediately transferred into plate reader, 
shaken for 10 sec to mix and product formation was measured ~20 sec for 120 cycles at 290 nm. 
 
Only the 100 µM condition restored activity, supporting our hypothesis that the purified enzyme was apoprotein 
and binds PLP poorly, requiring supplementation of PLP to re-form a functional holoenzyme.  Thus, we chose to 
supplement PLP in the subsequent purified protein reactions. 
 
B5 and G6 small-scale analytical reactions 
 
Reactions were performed in 2 mL glass HPLC vials (Agilent) charged with nucleophile (final conc. 20 mM) 
dissolved in DMSO (5% w/v), followed by the addition of purified protein (final enzyme conc. either 2 μM or 
40 μM), PLP (final conc. 100 μM)  and serine (final conc. 20 mM) to achieve a final volume of 200 μL. Reactions 
were incubated at 30 °C for ~24 hours. Reactions were diluted with 600 μL 2:1 CH3CN/1 M aq. HCl, subjected 
to centrifugation at 5,000g, and 400 μL transferred to 2 mL glass HPLC vials (Agilent). Samples were analyzed 
by HPLC-MS. Azulene samples were further diluted 20X to avoid oversaturation of the UV-detector and analyzed 
via UHPLC-MS. 
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 Supplementary Tables 
 
Supplementary Table 1 | Summary of all cultures passaged for evolution of TmTrpB 
variants. 
TrpB variant (strain) culture volume (mL) 
total number 
passaged 
total number 
successful 
wt TmTrpB (GR-Y053) 3 4 1 100 2 2 
TmTriple (GR-Y055) 3 8 2 100 4 4 
TmTripleQ90* (GR-Y057) 3 8 1 100 0 0 
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Supplementary Table 2 | Mutation summary statistics for OrthoRep-evolved TrpB 
populations. 
  non-synonymous mutations synonymous mutations 
variant set 
total 
number of 
sequences 
total 
unique 
mutations 
mean standard deviation mean 
standard 
deviation 
consensus 10 43 5.6 2.3 3.0 2.3 
1 16 85 8.7 2.1 6.3 4.4 
2 60 194 9.3 2.8 6.5 3.0 
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Supplementary Table 3 | Mutations and identification information for all individual 
TmTrpB sequences. (See Supplementary_Table_3_Extended.xls for mutations and 
sequences.) 
variant 
set 
variant 
ID 
variant 
name 
evolution 
population 
number of 
non-
synonymous 
mutations 
number of 
synonymous 
mutations 
starting 
sequence 
1 A Tm11g Tm11 13 3 TmTrpB 
1 B Tm12f Tm12 9 7 TmTrpB 
1 C Tm1Ff Tm1F 7 1 TmTrpB 
1 D Tm4Ge Tm4G 6 11 TmTripleQ90* 
1 E Tm4Gf Tm4G 11 15 TmTripleQ90* 
1 F Tm3Cc Tm3C 9 3 TmTriple 
1 G Tm3Cf Tm3C 9 3 TmTriple 
1 H Tm3Cg Tm3C 11 4 TmTriple 
1 R Tm3Df Tm3D 9 6 TmTriple 
1 J Tm33f Tm33 10 5 TmTriple 
1 K Tm34e Tm34 9 7 TmTriple 
1 L Tm34f Tm34 8 6 TmTriple 
1 M Tm35f Tm35 5 3 TmTriple 
1 N Tm36b Tm36 7 11 TmTriple 
1 O Tm36e Tm36 10 1 TmTriple 
1 P Tm36f Tm36 6 14 TmTriple 
2 B1 Tm11-B1 Tm11 16 11 wt TmTrpB 
2 B3 Tm11-B3 Tm11 12 7 wt TmTrpB 
2 B4 Tm11-B4 Tm11 14 10 wt TmTrpB 
2 B6 Tm11-B6 Tm11 14 9 wt TmTrpB 
2 B8 Tm11-B8 Tm11 12 9 wt TmTrpB 
2 D5 Tm12-D5 Tm12 9 10 wt TmTrpB 
2 D4 Tm12-D4 Tm12 7 5 wt TmTrpB 
2 D8 Tm12-D8 Tm12 7 6 wt TmTrpB 
2 D7 Tm12-D7 Tm12 9 8 wt TmTrpB 
2 D6 Tm12-D6 Tm12 10 5 wt TmTrpB 
2 D3 Tm12-D3 Tm12 7 9 wt TmTrpB 
2 C2 Tm12-C2 Tm12 9 9 wt TmTrpB 
2 D1 Tm12-D1 Tm12 8 9 wt TmTrpB 
2 A1 Tm1F-A1 Tm1F 9 4 wt TmTrpB 
2 A7 Tm1F-A7 Tm1F 10 8 wt TmTrpB 
2 A6 Tm1F-A6 Tm1F 8 4 wt TmTrpB 
2 A5 Tm1F-A5 Tm1F 8 6 wt TmTrpB 
2 A4 Tm1F-A4 Tm1F 7 5 wt TmTrpB 
2 A3 Tm1F-A3 Tm1F 7 7 wt TmTrpB 
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2 A2 Tm1F-A2 Tm1F 8 4 wt TmTrpB 
2 A8 Tm1F-A8 Tm1F 6 2 wt TmTrpB 
2 F3 Tm4G-F3 Tm4G 14 8 TmTripleQ90* 
2 F5 Tm4G-F5 Tm4G 14 8 TmTripleQ90* 
2 F6 Tm4G-F6 Tm4G 11 9 TmTripleQ90* 
2 F7 Tm4G-F7 Tm4G 9 6 TmTripleQ90* 
2 F2 Tm4G-F2 Tm4G 16 6 TmTripleQ90* 
2 F1 Tm4G-F1 Tm4G 11 9 TmTripleQ90* 
2 C8 Tm3C-C8 Tm3C 10 5 TmTriple 
2 C5 Tm3C-C5 Tm3C 15 6 TmTriple 
2 D2 Tm3C-D2 Tm3C 9 4 TmTriple 
2 C1 Tm3C-C1 Tm3C 6 4 TmTriple 
2 C7 Tm3C-C7 Tm3C 12 3 TmTriple 
2 C3 Tm3C-C3 Tm3C 7 5 TmTriple 
2 E8 Tm3D-E8 Tm3D 8 11 TmTriple 
2 E3 Tm3D-E3 Tm3D 13 4 TmTriple 
2 E1 Tm3D-E1 Tm3D 10 3 TmTriple 
2 E2 Tm3D-E2 Tm3D 12 8 TmTriple 
2 G1 Tm33-G1 Tm33 5 5 TmTriple 
2 G2 Tm33-G2 Tm33 9 6 TmTriple 
2 G3 Tm33-G3 Tm33 6 5 TmTriple 
2 G4 Tm33-G4 Tm33 10 8 TmTriple 
2 G7 Tm33-G7 Tm33 7 2 TmTriple 
2 G5 Tm33-G5 Tm33 8 4 TmTriple 
2 G6 Tm33-G6 Tm33 6 5 TmTriple 
2 H3 Tm34-H3 Tm34 8 5 TmTriple 
2 H6 Tm34-H6 Tm34 10 15 TmTriple 
2 H4 Tm34-H4 Tm34 12 10 TmTriple 
2 H7 Tm34-H7 Tm34 10 10 TmTriple 
2 H2 Tm34-H2 Tm34 13 4 TmTriple 
2 H1 Tm34-H1 Tm34 9 15 TmTriple 
2 H5 Tm34-H5 Tm34 9 10 TmTriple 
2 C6 Tm35-C6 Tm35 6 2 TmTriple 
2 B2 Tm35-B2 Tm35 8 4 TmTriple 
2 B5 Tm35-B5 Tm35 5 2 TmTriple 
2 B7 Tm35-B7 Tm35 6 3 TmTriple 
2 C4 Tm35-C4 Tm35 7 3 TmTriple 
2 E5 Tm36-E5 Tm36 6 8 TmTriple 
2 E7 Tm36-E7 Tm36 8 7 TmTriple 
2 E4 Tm36-E4 Tm36 6 6 TmTriple 
2 F8 Tm36-F8 Tm36 7 5 TmTriple 
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 Supplementary Table 4 | Kinetic parameters of selected TmTrpB variants at 30 °C. 
variant kcat [95% credible region] (s-1) 
KM [95% credible 
region] (µM) 
kcat/KM [95% credible 
region] (mM-1 s-1) 
TmTriple 0.2 [0.16, 0.31] 41.23 [14.32, 192.66] 4.89 [1.54, 12.12] 
C 0.53 [0.49, 0.58] 3.89 [1.85, 7.99] 137.22 [70.29, 276.04] 
D 0.77 [0.72, 0.83] 5.79 [3.82, 8.8] 133.38 [91.24, 193.71] 
K 0.62 [0.59, 0.66] 5.58 [3.99, 7.91] 111.89 [81.52, 152.25] 
  
was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 
The copyright holder for this preprint (whichthis version posted June 2, 2020. . https://doi.org/10.1101/2020.06.01.128165doi: bioRxiv preprint 
Supplementary Figures 
 
 
Supplementary Fig. 1 | Evaluation of indole-dependent TRP5 complementation of TrpB 
variants. a-c, Spot plating assays for Dtrp5 yeast strains expressing TrpB variants from a nuclear 
plasmid under two different promoter strengths (a), from a nuclear plasmid under a strong 
promoter (b), or from p1 at a high copy number (wt TP-DNAP1 expressed in trans) (c) grown on 
indicated growth medium.  
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Supplementary Fig. 2 | In vivo Trp production by evolved TrpBs. a, Spot plating assay for 
TRP5-deleted yeast with a nuclear plasmid expressing TRP5, TmTriple, or an individual 
OrthoRep-evolved TmTrpB variant driven by a promoter (pRNR2) that approximates expression 
of TmTrpB variants from OrthoRep’s p1 plasmid, grown on indicated media. b, Evaluation of 
TRP5 complementation by evolved variants through a growth rate assay. Maximum growth rates 
over a 24-hour period for Δtrp5 yeast strains transformed with a nuclear plasmid expressing the 
indicated TmTrpB variant, grown in medium with or without 100 μM indole, and with or without 
Trp, as indicated. Points and error bars represent mean ± s.d. of four technical replicates, 
respectively. c, Optimization of indole concentration. Growth rates during exponential growth for 
Dtrp5 yeast with a nuclear plasmid expressing randomly chosen OrthoRep-evolved TrpB variants 
(exact sequence not determined), supplemented with one of four indole concentrations, Trp, or 
neither of these. Bars and error bars represent mean ± s.d. of four technical replicates, 
respectively. 
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 Supplementary Fig. 3 | In vitro Trp production by evolved TrpBs with heat treated lysate. 
Trp production at 30 °C by indicated TmTrpB variants. Reactions with TmTriple were performed 
with both heat treated lysate and with purified protein, while all other reactions were performed 
only with heat treated lysate. TTN, total turnover number. Maximum TTN is 5,000. Points 
represent TTN for individual replicates, bars represent mean TTN for reactions with replicates, or 
TTN for a single replicate otherwise. 
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Supplementary Fig. 4 | In vitro Trp and Trp analog production with purified enzyme. a,b, 
Production of (a) Trp at 30 °C or 75 °C with 40,000 maximum TTN or (b) indicated Trp analogs at 
30 °C by column purified TmTrpB variants. TTN, total turnover number with 10,000 as maximum 
TTN. Points represent TTN for individual replicates, bars represent mean TTN for reactions with 
replicates, or TTN for a single replicate otherwise. 
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Supplementary Fig. 5 | Thermal shift assay on various TmTrpBs. Proportion of TmTrpB 
variants TmTriple (a), C (b), D (c), or K (d) that remain folded after incubation at indicated 
temperature for 1 hour, as measured by the fraction of Trp production relative to incubation at 25 
°C. T50, temperature at which 50% of enzyme is irreversibly inactivated, as estimated by best fit 
logistic model (dotted line). Each temperature tested in duplicate.  
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Supplementary Fig. 6 | Michaelis-Menten plots for rate of Trp production at saturating 
serine for evolved TmTrpB variants. Initial rate of Trp formation (k, per second) with TrpB 
variants TmTriple (a), C (b), D (c), or K (d) at saturating serine concentration (40 mM) vs. indole 
concentration. Points, median estimates for initial rate based on absorbance change over time 
(see Methods). The median estimated Michaelis-Menten curve is shown as a dark green line, 
with the 25, 50, 75, and 95% credible regions displayed from dark to light green, respectively. All 
measurements performed in at least duplicate.  
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Supplementary Fig. 7 | Relatedness of TrpB panel sequences generated by OrthoRep 
evolution. Force directed graph where each node represents an individual sequence (all variants 
from set 2, and variants C, D, and K) or consensus sequence for one of the ten evolved 
populations. Edge weights are proportional to the number of shared mutations between two 
nodes. Higher edge weight yields a stronger attractive force between two nodes, and is visualized 
as a darker color and a thicker line. Nodes for individual sequences are colored according to initial 
rate of Trp formation, similar to Fig. 3b. Dotted lines are drawn around consensus sequences and 
individual sequences that are derived from the same evolved culture, if nodes are sufficiently 
clustered to allow it. 
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Supplementary Fig. 8 | TrpB panel indole activity by initial rate of Trp formation. Initial rate 
of Trp formation at saturating L-serine by UV-vis spectrophotometry. Points represent rate for 
individual replicates, bars represent mean rate for reactions with multiple replicates, or rate for a 
single replicate otherwise. OrthoRep-evolved variants are ordered first by the population from 
which they were derived, then by indole activity. Empty, expression vector without TrpB variant. 
Sterile, reaction master mix without heat-treated lysate added. Empty, Pf2B9, TmAzul, Tm9D8*, 
TmTriple, C, D, and K all performed in quadruplicate; sterile performed in duplicate; all other 
reactions performed in a single replicate. 
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Supplementary Fig. 9 | TrpB panel activity with indole analogs by HPLC yield. a-i, HPLC 
yield of (a) 5-cyanoTrp, (b) 6-cyanoTrp, (c) 7-cyanoTrp, (d) 5-bromoTrp, (e) 6-bromoTrp, (f) 7-
bromoTrp, (g) 5-methoxyTrp, (h) 5-trifluoromethylTrp, and (i) β-(1-azulenyl)-L-alanine for 
indicated variants supplied with L-serine and each indole substrate. Points represent % yield for 
individual replicates, bars represent mean % yield for reactions with replicates, or % yield for a 
single replicate otherwise. Replicates and variant order are as in Fig. S8, and populations from 
which OrthoRep-evolved variants were derived are annotated. 
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 Supplementary Fig. 10 | Substrate activity profiles for large scale purification of variants 
B5 and G6. Total turnover number (TTN) for TmTrpB variants B5 and G6 purified at large scale 
(see Methods) and supplied with L-serine and the indicated indole analog, azulene, or indole 
(nucleophile), with a maximum TTN of 10,000. All reactions were performed in duplicate. Points 
represent TTN for individual replicates, bars represent mean for two replicates. Insets, TTN for 5-
trifluoromethylindole with y-axis scale adjusted for clarity.  
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 Supplementary Fig. 11 | Commonly observed mutations at the α-subunit interaction 
interface. a, Homology-predicted TmTrpB structure (based on engineered stand-alone PfTrpB, 
PDB 6AM8), with commonly mutated TmTrpB residues located near the TrpA interaction interface 
highlighted. Solvent-exposed regions of TrpA (purple) (PDB 1WDW) are shown as a surface. 
Mutations are indicated by the wt residue and position, followed by any residues to which this wt 
residue is mutated in OrthoRep-evolved TrpB sequences. b, Total number of sequences in both 
variant sets 1 and 2 that contain the indicated number of mutations to any of the residues 
highlighted in panel a.  
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 Supplementary Fig. 12 | Commonly observed mutations to residues near a catalytic α-helix. 
a, Homology-predicted TmTrpB structure (aligned to engineered stand-alone PfTrpB, PDB 6AM8) 
with wt residues on or near the α-helix housing K83, which are commonly mutated in OrthoRep 
evolved populations (orange). PLP (green) and Trp (green) are shown as sticks, and the catalytic 
lysine K83 (teal) is shown as spheres. Mutations are indicated by the wt residue and position, 
followed by any residues to which this wt residue is mutated in OrthoRep-evolved TrpB 
sequences. Dotted lines connect the α-carbon of residues not located on the K83 α-helix with the 
α-carbon of the nearest residue on the K83 α-helix, with the distance noted in Ångstroms. b, Total 
number of sequences in both variant sets 1 and 2 that contain the indicated number of mutations 
to any of the residues highlighted in panel a. 
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 Supplementary Fig. 13 | First- and second-shell active site mutations. a-c, Homology model 
of TmTrpB (aligned to PfTrpB, PDB: 6AM8) highlighting residues mutated in OrthoRep-evolved 
variants (orange) that may influence (a) indole charge, (b) PLP six-member ring binding, and (c) 
PLP-phosphate binding. Mutations are indicated by the wt residue and position, followed by any 
residues to which this wt residue is mutated in OrthoRep-evolved TrpB sequences. d, Total 
number of sequences in both variant sets 1 and 2 that contain the indicated number of mutations 
to any of the residues highlighted in panels a, b, or c. 
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 Supplementary Fig. 14 | Sequence divergence for natural and OrthoRep-evolved TrpBs. a-
b, Distributions of pairwise % amino acid sequence divergence for a diverse group of 38 naturally 
occurring mesophilic TrpB variants (a) and OrthoRep-evolved variant sets 1 and 2 (b). 
 
was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 
The copyright holder for this preprint (whichthis version posted June 2, 2020. . https://doi.org/10.1101/2020.06.01.128165doi: bioRxiv preprint 
